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Induction of adipose conversion i 3T3-Lf by bezafibrate has been previously shown to be enhanced by dibutyryl CAMP and to be associated with 
an early phosphorylation of a 60 kDa acidic protein [Biochim. Biophys. Acta 1054 (1990) 219-224; FEBS Lett. 285 (1991) 63-651. We describe 
here the isolation and sequencing of two peptides of the protein concerned. Both appear to be homologous with two respective amino acid sequences 
of the mouse intermediate filament protein vimentin. 
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I. INTRODUCTION 
H~olipidemic a~loxyalkanoic acids of varying hy- 
drophobic backbones (i.e. clofibric acid, bezafibrate) 
have been reported to induce adipose conversion in cul- 
tured 3T3-Ll cells as well as in primary rat epididymal 
preadipocytes imilar in nature and extent to that in- 
duced by IBMX [1,2]. The induction of adipose conver- 
sion in 3T3-Ll cells by bezafibrate was found to be 
synergistic with but,-CAMP, forskolin or theophylline. 
The synergistic effect required the simultaneous pres- 
ence of the fibrate inducer and but,-CAMP in the culture 
medium during the induction phase (usually 48 h), after 
which both could be replaced by an ins~in-containing 
medium, allowing for the differentiated cells to develop 
gradually into mature adipocytes [3]. The earliest 
change observed during bezafibrate/but,-CAMP- or 
IBMX-induced adipose conversion consisted of a phos- 
phorylation of a 60 kDa acidic protein precipitating 
with the nuclear fraction 141. The correlation observed 
between induction of adipose conversion and phospho- 
rylation of a discrete protein by the concerned effecters 
might indicate that phosphorylation of the 60 kDa pro- 
tein could be intrinsic to the inductive sequel of adipose 
conversion. The concerned protein has now been iso- 
lated and sequenced and found to be partly homologous 
with mouse vimentin. 
Tyrode solution supplemented with 0.4% fatty acid-free bovine serum 
albumin. Following equilibration of the intracellular pool of ATP with 
“P the SzP-labelled ceils were incubated for an ad~tional2 h with 1 
,& dexamethasone and either 300 PM bezafibrate, 50 FM but,- 
CAMP, both or with 500 PM IBMX. The medium was then removed 
and the cells were washed with saline (4 x 1.0 ml). A nuclei-rich frac- 
tion was prepared by lysing the cultured cells in 1.5 ml/plate of a 
solution composed of 10 mM Tris-HCl buffer, pH 7.5, 5 mM MgCl,, 
25 mM KCl, 0.1 mM EDTA, 1 mM DlT and 0.5 mM Nonidet P-40, 
followed by centrifuging the cell lysate for 5 min at 500 x g as de- 
scribed by Zechner et al. [5] and Doglio et al. [6]. 
The nuclei-rich fraction derived from a 6 cm dish was either dis- 
solved in 100 ,uI of ZD-PAGE loading buffer, composed of 9.3 M urea, 
2% Nonidet P-40,5% ampholines @H 3-10) and 5% mercaptoethanol, 
and subjected to 2-dimensional gel electrophoresis, or was extracted 
at 0°C by 0.5 ml of an ice-cold extraction medium prepared according 
to Dignam [7] (20 mM HEPES, pH 7.9,25% glycerol, 0.42 M NaCl, 
1.5 mM MgCl,, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTT) 
or Nervi [S] (10 mM Tris-HQ, pH 8.5, 1.5 mM EDTA, 2 mM DTT, 
0.5 mM PMSF, 10% glycerol and 0.8 M KC]). The suspended precip- 
itate was forced 10 times up and down a pipetor’s plastic tip, vortexed 
for 10 min and left on ice for 30 min. The non-extractable residue was 
precipitated by a 5 min centrifugation at 4”C, 25,000 x g. The extracts 
were dialyzed at 0°C against 2 x I I of H,O, lyop~lized and dissolved 
in the ZD-PAGE loading buffer. The non-extractable residue was 
similarly dissolved in the same buffer. 
2D gel electrophoresis was carried out as described by G’Farrel[9], 
using molecular weight markers from an Amersham ‘Rainbow’ kit 
and pH markers from a Pharmacia ‘Carbamylate’ kit. For autoradi- 
ography, the gels were tied in 10% (v/v), acetic acid1256 methanol 
(v/v) in water, dried and exposed to X-ray film at -70°C. 
2. MATERIALS AND METHODS 
3T3-Ll cells were grown to confluence in 35 or 60 mm plates in 
DMEM supplemented with 10% FCS as previously described [2] and 
subsequently incubated for 2 h with ]‘*P]H3P0, in a phosphate-fry 
For sequencing, the 60 kDa protein was el~trob~otted for 20 h from 
the 2D gel to a PVDF membrane at a current density of 2 mA/cmZ in 
0.005% SDS and 10% methanol in x 0.5 Towbin buffer [IO]. Enzy- 
matic cleavage of the 60 kDa protein was carried out as described by 
Cleveland et al. [11] by applying the SDS-gel piece containing the 
protein onto another 15% SDS gel together with the SDS-resistant V8 
protease. Following cleavage on the gel the resulting peptides were 
separated el~trophoreti~Iy on the 15% SDS gel, and electroblotted 
to a PVDF membrane as described above but in the absence of added 
SDS. 
*Corresponding author. Electroblotted proteins and peptides were identified on PVDF 
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membranes by both autoradiography and Coomassie blue staining (5 
min incubation with freshly prepared 0.025% Coomassie blue R250 
in 40% methanol, followed by destaining in SO% methanol and finally 
in H,O) and were semi-quantitated by comparing the color intensity 
with that of molecular weight markers. For microsequencing, the 
relevant PVDF pieces were cut out and pooled. Microsequencing was 
performed on a 475A protein sequencing system consisting of Model 
470A gas-phase microsequencer equipped with an on-line phenyl- 
thiohydantoin analyzer, Model 120A and 900A data system (Applied 
Biosystems, Foster City, CA). The protein samples on PVDF were 
subjected to Edman degradation in a modified reaction cycle [12]. 
Conversion of the thiazolinone derivatives to phenylthiohydantoin- 
amino acids was carried out with 25% TFA. Phenylthiohydantoin- 
amino acid derivatives were separated by reversed-phase HPLC on a 
PTH C,, column (2.1 x 220 mm; Applied Biosystems) using sodium 
acetate bufferltetrahydrofuramacetonitrile gradient [13]. A computer 
search was carried out in ‘Swiss-Prot’ and ‘PIR-Protein’ data bases, 
using GCG package, version 7, of Genetic Computer Group, Madi- 
son, Wisconsin. 
For immunoblotting, the 60 kDa protein was similarly electroblot- 
ted from the 2D gel to a nitrocellulose membrane in 20% methanol. 
Immunoblot assays were carried out essentially as described by Mani- 
atis [22] using either polyclonal goat anti human vimentin antibodies 
(Sigma) or monoclonal mouse anti human vimentin antibodies (Vim- 
13.2, Sigma). The respective first antibody was detected with an anti- 
goat or an antimouse polyvalent antibody conjugated to alkaline 
phosphatase (Sigma). 3% BSA was used for blocking. 
3. RESULTS 
The 60 kDa protein to be analyzed was identified by 
2D SDS-PAGE of the nuclei rich fraction of 32Pi-la- 
belled bezafibrate/bu,-CAMP- or IMBX-induced 3T3- 
Ll cells as previously described (Fig. 2, ref. 4). The 60 
kDa protein could not be extracted from the nuclei-rich 
fraction by standard procedures for preparing nuclear 
extracts using extraction media described by Dignam et 
al. or Nervi et al. (containing 0.42 or 0.80 M NaCl, 
respectively) [7,8]. It was however fully recovered in the 
non-extractable nuclear residue. For sequencing, 50- 
100 pmol of the 60 kDa protein were electroblotted 
from the 2D SDS-PAGE to a PVDF membrane and 
subjected to automated Edman degradation. No signal 
was however generated after the first 10 cycles, indicat- 
ing that the amino end of the isolated protein was pre- 
sumably blocked. To overcome this difficulty, the pro- 
tein was enzymatically cleaved into peptides separated 
by 15% SDS-PAGE prior to microsequencing, as de- 
scribed in Section 2. Two resulting peptides were sub- 
jected to microsequencing, a radioactive one of 14 kDa 
(peptide 1) and a shorter one (peptide 2) (Fig. 1). Amino 
acid sequences found at the NH2 termini of peptides 1 
and 2, respectively, were as follows: 
348-360 of mouse vimentin. Both vimentin sequences 
were found to be preceded by glutamic acid as expected 
from the specificity of protein cleavage by V8. Peptide 
1 was also found to be partly homologous with a se- 
quence (a.a. Nos. 35-50) of mouse lamin and the 
‘QELND’ motif could be identified within several other 
structural proteins, such as desmin and periferin. The 
sequence of peptide 2, however, could be identified 
within vimentin only but not within lamin or any of the 
other proteins. 
The homology of the 60 kDa protein with vimentin 
was further confirmed by reacting the blotted 2D SDS 
gel with either polyclonal or monoclonal anti-vimentin 
antibodies (Fig. 2). Both were found to specifically react 
with the concerned 32P-labelled protein. 
4. DISCUSSION 
Peptide 1: L-Q-E-L-N-D-A-F-M-R-Y-I-D-K-V-R-F 
Peptide 2: N-F-A-L-E-A-A-N-Y-Q-D-T 
In addition to our sequencing and immunoblotting 
results, some other known properties of vimentin agree 
with the characteristics of the 60 kDa protein: (i) Vi- 
mentin is a cytoskeleton protein, being non-extractable 
by salt or detergent, which precipitates with the nuclear 
fraction under conditions of cell fractionation as em- 
ployed here [14]; (ii). Its reported molecular weight (54 
58 kDa) and PI (5.2) [14,20] agree with the respective 
characteristics of the 60 kDa protein [4]; (iii) vimentin’s 
reported susceptibility to N-acetylation [I 51 is in line 
with the blocked N-terminal end of the 60 kDa protein 
as reported here. 
Peptide 1 sequence was best matched with the stretch Phosphorylation and dephosphorylation of vimentin 
of amino acids Nos. 106123 of mouse vimentin (mis- have been well documented and suggested to be in- 
matches are marked by arrows). Peptide 2 sequence was volved in cytoskeleton reorganization associated with 
similarly found to fully match the stretch of amino acids processes of cell division and differentiation [15-181. 
Fig. 1. V8 cleavage of the 60 kDa “P-labelled protein. The 60 kDa 
“P-1abelled protein cleaved by V8 protease and electrophoresed on a 
15% SDS gel as described in Section 2. Peptides were detected by 
Coomassie blue staining (a) as well as by radioactivity (b) monitored 
by phosphorimaging (Fuji). Peptides 1 and 2 are denoted by arrows. 
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Fig. 2. Immunoblotting the 60 kDa ‘*P-labelled protein with an- 
tivimentin. Nuclear proteins from ‘*P-1abelled bezafibratelBut,- 
CAMP-induced cells were electrophoresed by 2D SDS-PAGE, as de- 
scribed in Section 2. (A) Coomassie staining; (B) autoradiogram; (C) 
immunoblot with polyclonal antivimentin antibodies; (D) Im- 
munoblot with monoclonal antivimentin antibodies. The arrows point 
to the relevant protein. 
Phosphorylation of vimentin in the course of adipocyte 
maturation could thus initiate its rearrangement in cells 
induced for lipid accumulation. It has indeed been re- 
ported by Franke et al. [ 193 that rearrangement of inter- 
mediate filament proteins, including vimentin, is in- 
volved in the formation of the fat droplet protein mem- 
brane during adipose conversion of 3T3-Ll cells. Fur- 
thermore, phosphorylation and dephosphorylation of 
protein components of the ‘lipid droplet cage’, including 
vimentin and perilipin, have recently been suggested by 
Londos et al. [20] to be involved in regulation of lipoly- 
sis in mature adipocytes. It is noteworthy that a protein 
encoded by pOb24 previously reported as an early 
marker of adipose converion, has recently been identi- 
fied to be homologous with the a chain of collagen type 
VI [21], thus indicating that the expression, modifica- 
tion and rearrangement of structural proteins may com- 
prise some of the earliest events in the course of adipose 
conversion. 
In spite of the apparent 32P-labelling of peptide 1 (Fig. 
2), the site of bezafibrate/cAMP-induced phosphoryla- 
tion of 3T3-Ll vimentin may not be inferred from stud- 
ies reported here. An RKXXS protein kinase A motif 
which could serve as a potential site for phosphoryla- 
tion [23] may indeed be identified within the 14 kDa 
peptide 1 (a.a. 221-225). It should be noted however, 
that all previously reported protein kinase A-phospho- 
rylation sites of vimentin are rather located within the 
stretch of the first 70 amino acids starting at the blocked 
NH,-terminus while the RKXXS site at a.a. 221-225 
has not been previously reported to be phosphorylated 
by protein kinase A in vitro [24] or in vivo [25]. Alterna- 
tively, the radioactivity co-electrophoresed with peptide 
1 following V8 cleavage could perhaps be accounted for 
by an additional 14 kDa peptide derived from the first 
N 140 a.a. of vimentin and which co-electrophoresed 
with a non-labelled 14 kDa peptide 1. Being blocked in 
its NH,-terminus, this additional peptide could not in- 
terfere with the sequencing of peptide 1 but still may 
account for 32P-labelling of vimentin induced by bezafi- 
brate/cAMP. 
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